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Objectives: The increase in the routine use of abdominal imaging has led to a parallel surge in the
identification of polypoid lesions in the gallbladder. True gallbladder polyps (GBP) have malignant poten-
tial and surgery can prevent or treat early gallbladder cancer. In an era of constraint on health care
resources, it is important to ensure that surgery is offered only to patients who have appropriate
indications. The aim of this study was to assess treatment and surveillance policies for GBP among
hepatobiliary and upper gastrointestinal tract surgeons in the UK in the light of published evidence.
Methods: A questionnaire on the management of GBP was devised and sent to consultant surgeon
members of the Association of Upper Gastrointestinal Surgeons (AUGIS) of Great Britain and Ireland with
the approval of the AUGIS Committee. It included eight questions on indications for laparoscopic
cholecystectomy and surveillance based on GBP (size, number, growth rate) and patient (age, comor-
bidities, ethnicity) characteristics.
Results: A total of 79 completed questionnaires were returned. The vast majority of surgeons (>75%)
stated that they would perform surgery when a single GBP reached 10 mm in size. However, there was
a lack of uniformity in the management of multiple polyps and polyp growth rate, with different surveil-
lance protocols for patients treated conservatively.
Conclusions: Gallbladder polyps are a relatively common finding on abdominal ultrasound scans. The
survey showed considerable heterogeneity among surgeons regarding treatment and surveillance pro-
tocols. Although no randomized controlled trials exist, national guidelines would facilitate standardization,
the formulation of an appropriate algorithm and appropriate use of resources.
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Introduction
Polypoid lesions of the gallbladder (PLG) are reported increas-
ingly as a result of the wider use of abdominal ultrasound (US)
and do not represent a rare finding in general and subspecialty
clinics. Estimated prevalences of PLG vary, but they are generally
considered to occur in around 5% of the population in the
Western world.1 The majority of PLG are benign, and cholesterol
polyps, adenomyomatosis and inflammatory polyps are the most
common aetiologies. A small minority (5%) of PLG are ‘true’
adenomatous gallbladder polyps (GBP) with malignant poten-
tial.2 It is estimated that 3–8% of GBP are malignant3 and that
of adenomatous polyps measuring > 10 mm, about 50% will
harbour cancerous cells.4,5 In the UK, approximately 50 000 lap-
aroscopic cholecystectomies (LCs) are performed each year, of
which 800–4000 are estimated to be for GBP.6–8 Currently, chole-
cystectomy is usually considered appropriate for large polyps
(>10 mm), based on the assumption that the risk for malignant
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transformation rises steeply in polyps measuring >10 mm.
However, some studies have shown that, although uncommon,
malignant polyps can be smaller in size, especially in the Asian
population.9 Age, number of polyps and growth rate are less clear
indications for surgery. Gallbladder polyps that arise in a context
of primary sclerosing cholangitis (PSC) are considered to carry a
higher risk for malignancy and thus cholecystectomy is advocated
even for GBP of <10 mm.10 No conclusive data are available
regarding surveillance protocols for GBP that are not removed
because the natural history of incidentally found GBP is still
uncertain and the lack of randomized controlled trials (RCTs)
does not help the surgeon’s decision-making process. In January
2010, the Society of American Gastrointestinal and Endoscopic
Surgeons (SAGES) updated its guidelines on the clinical applica-
tion of laparoscopic biliary tract surgery and concluded that: ‘the
management of gallbladder polyps remains controversial. A rea-
sonable approach would include laparoscopic cholecystectomy for
larger, especially single, polyps or those with associated symptoms
with watchful waiting for small (<5 mm) asymptomatic polyps
(Level II grade B evidence).’11
The aim of this study was to evaluate current treatment and
surveillance strategies for GBP among hepatobiliary and upper
gastrointestinal (GI) tract surgeons in the UK and Ireland and to
discuss these in the light of the published literature.
Materials and methods
A questionnaire containing multiple-choice items on the manage-
ment of GBP was devised and sent by e-mail to consultant
surgeon members of the Association of Upper Gastrointestinal
Surgeons (AUGIS) of Great Britain and Ireland with the approval
of the AUGIS Committee. The e-mail included a link to a survey
website (http://www.surveymonkey.com). Responses to the ques-
tionnaire were collected anonymously. The survey required only
one answer to each question and included no open questions. The
survey focused on: (i) indications for treatment; (ii) surveillance
protocols for patients who fall outside criteria for surgery, and (iii)
patient selection.
Items related to the following questions:
1 When would LC be considered for a single GBP according to
size?
2 When would LC be considered for multiple GBP according to
the size of the larger polyps?
3 What growth rate of polyps between surveillance US scans
would prompt the surgeon to consider LC?
4 When would LC be considered in relation to an increase in the
number of polyps on surveillance US?
5 What is the protocol for the follow-up of patients who do not
match criteria for surgery?
6 Which patients would be considered for surgery according to
ASA (American Society of Anesthesiologists) grade?
7 Which patients according to age would be considered for
surgery (assuming there are no medical or anaesthetic
contraindications)?
8 Is the threshold for surgery for asymptomatic solitary or
multiple polyps influenced by ethnicity?
Results and discussion
A total of 402 e-mails were sent to consultant surgeon members of
AUGIS and 79 completed questionnaires were returned (19.7%
response rate).
Gallbladder polyps are generally thought to be asymptomatic
and indeed are commonly described as incidental findings on
radiological imaging. A smaller proportion of patients may be
symptomatic with typical biliary symptoms, but GBP are often
associated with gallstones, which makes it difficult to establish
whether they are responsible for the reported symptomatology.12,13
There is general agreement that small (<10 mm) symptomatic
polyps should be removed.14 Gallbladder cancer (GBC) is a
relatively rare neoplasm in the UK, but cumulative 5-year
survival rates are only 5–10% and the removal of premalignant
lesions in a relatively minor surgical operation is appealing.15
However, although LC is well established and is considered a ‘safe’
surgical procedure that can be performed in a day case context in
the majority of patients, complications can still arise and the
appropriateness of surgical indications is paramount when
resources are limited.
Question 1: when would LC be considered in
single GBP?
A total of 75.9% of surgeons agreed that 10 mm is regarded as the
size threshold for surgery for a single polyp, although 20.2% of
responders said they would consider surgery for smaller polyps
(Table 1). There is a general consensus that solitary polyps of
>10 mm are an indication for LC as a result of the increased risk
for malignancy. It is considered that 45–67% of GBP of >10 mm
aremalignant.5,7,8,13,16 Koga et al. reviewed 411 patients who under-
went cholecystectomy and found that of 40 GBP, eight were
adenocarcinomas.4 Seven of eight (87.5%) cancers and two of
Table 1 When would laparoscopic cholecystectomy be considered
for a single gallbladder polyp according to size?
Answer options Responses,
n (%)
One polyp measuring 12 mm on ultrasound 0
One polyp measuring 10 mm on ultrasound 60 (75.9%)
One polyp measuring 8 mm on ultrasound 4 (5.1%)
One polyp measuring 5 mm on ultrasound 8 (10.1%)
One polyp of any dimension 4 (5.1%)
Only when associated with gallstones (asymptomatic) 0
Only when associated with biliary symptoms 3 (3.8%)
Never recommend cholecystectomy 0
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32 (6.3%) GBP measured >10 mm, and seven of nine (77.8%)
polypoid lesions measuring >10 mm were malignant.4 Other
studies recommend LC for polyps of <10 mm in size when there
are symptoms or concomitant presumed risk factors for cancer
such as age >50 years or gallstones.13,17,18 Ito et al. studied a cohort
of 417 patients with PLG detected on US and concluded that small
PLG (<10 mm) can safely be observed and that PLG of <6 mm in
size on US rarely represent true adenomas.12 Although a plethora
of data suggest that 10 mm should be considered as a cut-off size
for LC, other studies recommend caution. A recent retrospective
study of 130 patients in the Mayo Clinic reported an incidence of
7.4% of neoplasia in polyps of <10 mm.19 Polyp size of >6 mm,
local invasion and vascularity on US and history of PSC were
considered significant risk factors for malignancy.19 Shinkai et al.
observed in a cohort of 74 patients that 6% of adenomas/
carcinomas occurred in polyps of <5 mm.20 Roa et al. analysed
pathological features of 219 GBP post-LC in a Chilean population
and found 15% to be adenomas and >67% of adenomatous
polyps to measure <10 mm; adenomas with malignant degenera-
tion were <5 mm in two of eight patients with underlying carci-
noma.21 Thus, it is clear that larger polyps are likely to harbour
neoplasic tissue, but neoplasia cannot be confidently excluded in
smaller polyps. Similarly, Park et al.3 studied a cohort of 1558
patients and found that in 45.5% of cancerous polyps (15/33), the
size of the GBP at diagnosis was <10 mm; these authors suggested
that the size-related threshold should be lowered to 8 mm,
although this would improve US sensitivity by only 9% and
decrease specificity by 8%. Park and colleagues concluded that
even small polyps carry a risk for malignancy and longterm
follow-up of GBP would help to detect and treat early GBC.3
Although endoscopic US has been shown to improve
diagnostic accuracy (benign vs. malignant) by up to 97% in the
diagnosis of smaller PLG, this approach is logistically and
economically impractical.22 On the basis of the reported literature,
although the risk for malignant transformation appears to be very
low for polyps of <10 mm, it is the present authors’ opinion that
it would not seem unreasonable to consider lowering the size
threshold for LC to <10 mm, although no clear cut-off can be
recommended.
Question 2: when would LC be considered in
multiple GBP?
In multiple GBP, 50.6% of responding surgeons would consider
LC when at least one of the polyps reaches 10 mm, and 34.1% of
surgeons would recommend LC even when the largest lesion mea-
sures <10 mm (Table 2). There is less clarity regarding the treat-
ment of multiple GBP.20 The number of lesions is unreliable in
determining the likelihood of gallbladder neoplasm. Cholesterol
polyps and adenomyomatosis tend to be multiple, whereas
adenomatous polyps are often solitary.20 Yang and colleagues
analysed 172 histologically proven PLG after cholecystectomy;
malignant lesions were seen in 7.6% (n = 13) of post-
cholecystectomy specimens, and all of them were >10 mm in
size and were solitary.17 Shinkai et al. found that neoplastic
polyps tended to be single (adenoma, mean number of polyps
1.40 0.89; cancer, mean number of polyps 1.16 0.40),
whereas half of cholesterol-related polyps were multiple (mean
number of polyps 3.09 3.31).20 However, when there were fewer
than three lesions, neoplasm was found in 37% of polyps measur-
ing 5–10 mm in diameter, prompting these authors to recom-
mend an aggressive surgical approach for small GBP numbering
fewer than three, regardless of size.20
Question 3: what growth rate of polyps prompts
consideration of LC?
A total of 48.2% of responding surgeons said they would perform
LC for any growth, whereas 51.8% would consider surgery only
when the polyp reaches the threshold for single polyp size (more
commonly 10 mm) (Table 3). Many studies have attempted to
clarify the natural history of GBP and reported growth rates are
extremely variable. Ito and colleagues12 retrospectively analysed
417 patients with GBP detected on abdominal US. In patients who
were monitored with serial abdominal US, 86% of polyps did not
change in size and 6% grew in size. Shin and colleagues23 retro-
spectively reviewed 145 patients who eventually underwent chole-
cystectomy. They found that a growth rate of <6 mm/month had
Table 2 When would laparoscopic cholecystectomy be considered
for multiple gallbladder polyps?
Answer options Responses,
n (%)
Multiple polyps, the largest measuring
12 mm on ultrasound
1 (1.3%)
Multiple polyps, the largest measuring
10 mm on ultrasound
40 (50.6%)
Multiple polyps, the largest measuring
8 mm on ultrasound
5 (6.3%)
Multiple polyps, the largest measuring
5 mm on ultrasound
11 (13.9%)
Multiple polyps of any dimension 11 (13.9%)
Only when associated with gallstones
(asymptomatic)
0




Table 3 What growth rate of polyps between surveillance ultra-




1 mm 5 (6.3%)
2 mm 11 (13.9%)
5 mm 22 (28%)
None unless the polyp reaches the ‘critical size’ 41 (51.8%)
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a negative predictive value of >90%. However, on multivariate
analysis the growth rate was not associated with malignancy,
regardless of polyp size. Thus, the investigators concluded that
GBP of <10 mm do not need to be removed simply because they
grow.23 Colecchia and colleagues24 prospectively followed 56
patients with small GBP (<10 mm) over 5 years with annual
abdominal US. No patients developed any clinical symptoms, and
no changes in polyp morphology were observed, suggesting that
the natural history of small GBP is benign. Csendes et al.25 studied
111 patients with PLG measuring <10 mm, of whom 80% had
PLG of <5 mm in size and 74% had single polyps. Thirteen
patients underwent cholecystectomy at their own request, and 14
patients in whom an increase in the number or size of PLG was
found on follow-up also underwent cholecystectomy.25 The
remaining patients who did not undergo surgery were followed
for a mean of 71 months. In the non-operative patients, PLG
remained static in size in 50.0% of patients, increased in size or
number in 26.5%, and shrank or disappeared in 23.5%. In the
patients who underwent surgery, no GBC was found. The authors
concluded that PLG of <10 mm did not progress to malignancy.25
However, Park et al.3 analysed over 1500 patients with a median
follow-up of 37 months and demonstrated invasive cancer in GBP
that grew from an original size of <10 mm (n = 15/33). It is not
possible to find in the literature any specific growth rate suggestive
of increased risk for malignancy.
Question 4: what increase in polyp numbers prompts
consideration of LC?
Answers to this item reflected a lack of consensus: 45.6% of
respondents recommended LC when an increase in the number of
polyps is detected (22.8% for any increase; 22.7% when three to
five more polyps were identified), whereas 54.5% stated they
would never recommend cholecystectomy (Table 4). The number
of polyps may increase or decrease between interval scans, but no
specific data on the likelihood of neoplasm have been reported in
this setting.
Question 5: what is the protocol for patients outwith
criteria for surgery?
Overall, 57.9% of surgeons said they would suggest US surveil-
lance at intervals of 6 months to 1 year for a maximum of 5 years
if there were no change in GBP features, whereas 15.7% would
continue surveillance for life (Table 5). A total of 10.5% would not
suggest any follow-up and another 15.8% suggested variable pro-
tocols, mostly including surveillance for up to 1 year if there were
no change in findings. This item probably represents the most
controversial issue as there is no agreement in the literature on
what might constitute an appropriate surveillance programme.
The majority of studies recommend 6-monthly US studies in the
first instance and suggest that, if there is no change after 1 year, the
frequency of examination should be determined on a case-by-case
basis in relation to risk factors.3,24,26,27 Other studies suggest initial
3-monthly scans with the purpose of identifying rapidly growing
polyps,28,29 and a recent retrospective series did not recommend
further surveillance for polyps of <6 mm and reported inconclu-
sive data for polyps of >7 mm.30 Several studies have followed
low-risk lesions for 15 years without reporting any marked
change in the size of lesions or the development of GBC.31,32 Rapid
growth can, however, be missed in intervals as short as 4 months.5
The length of follow-up is also unclear and some authors have
suggested that ongoing surveillance should be continued for as
long as 10 years.27
Question 6: which patients should be considered for
surgery based on ASA grade?
There is little in the literature about patient selection once an LC
is recommended, but it is interesting to note that when contem-
plating surgery, the majority of responding surgeons would rec-
ommend LC to all patients unless there were an absolute
anaesthetic contraindication, but 13.0% would consider LC only
in patients with ASA grades of 1 or 2 (Table 6).
Question 7: which patients should be considered for
surgery based on age?
A total of 54.5% of responding surgeons said they would consider
all patients for LC regardless of age if they met the criteria for LC
(assuming there were no absolute contraindications), but 29.9%
would exclude patients aged >80 years and 14.3% would exclude
patients aged >70 years (Table 7). Polyps in elderly patients (aged
Table 4 When would laparoscopic cholecystectomy be considered
in relation to an increase in the number of polyps on surveillance
ultrasound?
Answer options Responses, n (%)
For any increase 18 (22.8%)
Only for an increase of three or more 8 (10.1%)
Only for an increase of five or more 10 (12.6%)
Never 43 (54.4%)
Table 5 What is the protocol for the follow-up of patients who do not
match the criteria for surgery? (total answers to question 5 - n = 76)
Answer options Responses, n (%)
US every 6 months for life or until the polyp/
polyps reaches a critical size
3 (3.9%)
US every year for life or until the polyp/
polyps reaches a critical size
9 (11.8%)
US every 6 months for 2–5 years and then
stop; there should not be any significant
variation in size ( 1 mm) or number
13 (17.1%)
US every year for 2–5 years then stop; there
should not be any significant variation in
size ( 1 mm) or number
31 (40.8%)
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>50 years or >60 years, depending on the study considered) are
more likely to be neoplastic in nature, perhaps as a result of the
protracted presence of GBP or increased mutagenesis.4,13,17
Question 8: is consideration for surgery influenced
by ethnicity?
Overall, 89.9% of surgeons said they would not change their
approach to GBP treatment according to the patient’s ethnicity
(Table 8). It is, however, well established that some non-White
populations, most notably Indian and Chilean groups, are at
increased risk for GBC.33 A study among UK Indian patients who
underwent abdominal US (n = 1169) showed that the incidence of
cancer in GBP in such a population could potentially be higher
than in theWhite population.9 Findings showed two cases of GBC
in 36 (5.6%) Indian patients with GBP, compared with two cases
of GBC in 2228 (0.09%) White GBP patients (P < 0.001). Of
subjects with a single GBP, regardless of its size, Indian patients
seem to have a risk for developing GBC of one in 13 (7.7%),
whereas White patients have an equivalent risk of one in 670
(0.15%). Although the study included a very small number of
cancers, the results might suggest that the size threshold for LC
should be lowered for single GBP in this patient subgroup.9
Conclusions
The treatment and surveillance of GBP are still controversial as
a result of the lack of specific guidelines and RCTs. Gurusamy
and colleagues34 emphasized the difficulties inherent in organiz-
ing such a study that arise from the need to blind operators, the
long follow-up period required, the high likelihood of drop-out,
and the need to manage growing polyps and new-onset biliary
pain in the control cohort. The present survey, although it tar-
geted only surgeon members of a specific association, who cer-
tainly represent only a small sample of those engaged in this area
of practice in the UK, indicates that the majority of surgeons
would recommend LC for a single polyp that reaches 10 mm in
size. Generally, the presence of multiple polyps per se is not con-
sidered an indication for surgery; 51.8% of respondents did not
consider that growth rate necessarily mandates LC unless the
polyp achieves the appropriate size (usually 10 mm), and 54.5%
would not recommend LC when the number of polyps increased
between scans. Surveillance protocols differ, but 73.6% of sur-
geons would agree to ongoing surveillance for 5 years. The
majority of surgeons would consider surgery in all patients
regardless of age, assuming there were no anaesthetic contrain-
dications, but only a minority are influenced by the patient’s
ethnicity.
In the absence of RCTs, the provision of national guidelines
might help to reduce heterogeneity and standardize treatment and
surveillance of patients with GBP.
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